Two individuals died after recieveing stool transplants; a CDC report highlights a lack of action on binge drinking; Congress has approved a food aid measure for seniors.
Four individuals were hospitalized and 2 died after receiving stool transplants from OpenBiome, STAT News reports. Eight patients may have been affected by the treatment, which was marketed as potentially lifesaving for individuals with recurrent Clostridioides difficile infections. Around 12,800 Americans die from the infections each year. In the 6 living patients affected, OpenBiome was able to identify the bacteria that caused the complications, but neither the FDA nor the company is definitively saying stool transplants caused the deaths.
A survey released by the CDC found that although more than 75% of patients were asked about alcohol habits at checkups, less than half of the respondents were asked about binge drinking. Researchers note screening alone is not effective at reducing binge drinking, which is defined as 5 or more drinks on 1 occasion for men and 4 or more drinks for women. The practice can lead to complications like fetal alcohol syndrome and breast cancer. The survey also found that of respondents who fit the criteria, most weren’t offered any help.
A bipartisan bill was passed that advocates increasing money for nutrition programs to reduce the number of older Americans that go hungry, Kaiser Health News reports. However, the article notes the measure will not be sufficient to address the nation’s fast-growing senior population. Specifically, the measure calls for a 7% increase in funding for nutrition programs and other services over the first year and an additional 6% increase in each of the following 4 years. The measure will only take affect after Congressional appropriations committees decide on funding levels.
Eculizumab Biosimilar ABP 959 Demonstrates Similarity to Reference in Patients With PNH
December 6th 2023ABP 959, an eculizumab biosimilar in development, has demonstrated similar efficacy and pharmacokinetics to the reference product for patients with paroxysmal nocturnal hemoglobinuria (PNH), according to research at the 2023 American Society of Hematology Annual Meeting.
Read More
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More